These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26760985)

  • 21. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and breast cancer: may matrix metalloproteinase be the missing link.
    Mannello F; Tonti GA
    Cancer Invest; 2009 May; 27(4):466-70. PubMed ID: 19219650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
    Wang A; Wakelee HA; Aragaki AK; Tang JY; Kurian AW; Manson JE; Stefanick ML
    Curr Atheroscler Rep; 2016 Dec; 18(12):72. PubMed ID: 27796821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins as Anticancer Agents in the Era of Precision Medicine.
    Longo J; van Leeuwen JE; Elbaz M; Branchard E; Penn LZ
    Clin Cancer Res; 2020 Nov; 26(22):5791-5800. PubMed ID: 32887721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Statin Therapy on the Survival of Patients with Gastrointestinal Cancer.
    Gachpazan M; Kashani H; Khazaei M; Hassanian SM; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(7):738-747. PubMed ID: 30539694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins as Potential Therapeutics for Lung Cancer: Molecular Mechanisms and Clinical Outcomes.
    Fatehi Hassanabad A; McBride SA
    Am J Clin Oncol; 2019 Sep; 42(9):732-736. PubMed ID: 31335352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and the colorectum: hope for chemoprevention?
    Baron JA
    Cancer Prev Res (Phila); 2010 May; 3(5):573-5. PubMed ID: 20403999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and stroke: prevention and beyond.
    Prinz V; Endres M
    Curr Opin Neurol; 2011 Feb; 24(1):75-80. PubMed ID: 21150596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins for the prevention of colorectal carcinoma: not yet recommended].
    Koornstra JJ; Kleibeuker JH
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2388-91. PubMed ID: 16277127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems.
    Licarete E; Sesarman A; Banciu M
    J Microencapsul; 2015; 32(7):619-31. PubMed ID: 26299551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
    Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2002 Apr; 16(4):508-19. PubMed ID: 11960327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statins in the treatment of tumors. Fiction or a new therapeutic approach?].
    Vítek L; Kráslová I; Muchová L; Krechler T
    Cas Lek Cesk; 2003; 142(6):323-8; discussion 329-30. PubMed ID: 12924030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory and immunomodulatory effects of statins.
    Blanco-Colio LM; Tuñón J; Martín-Ventura JL; Egido J
    Kidney Int; 2003 Jan; 63(1):12-23. PubMed ID: 12472764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of statins in cancer therapy.
    Hindler K; Cleeland CS; Rivera E; Collard CD
    Oncologist; 2006 Mar; 11(3):306-15. PubMed ID: 16549815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The statins: multifunctional antithrombotic and antineoplastic drugs.
    Splichal JE; Stamm JA; Ornstein DL
    Semin Thromb Hemost; 2003 Jun; 29(3):259-74. PubMed ID: 12888930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.